Crossmark

Responsive neurostimulation in pediatric epilepsy: a systematic review and individual patient meta-analysis supplemented by a single institution case series in 105 aggregated patients

Crossref DOI link: https://doi.org/10.1007/s00381-024-06546-x

Published Online: 2024-07-26

Published Print: 2024-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rosenberg, A.

Wang, R.

Petchpradub, M.

Beaudreault, C.

Sacknovitz, A.

Cozzi, F. M.

Wolf, S. M.

McGoldrick, P. E.

Muh, C. R.
License Information

Text and Data Mining valid from 2024-07-26

Version of Record valid from 2024-07-26
More Information

Article History

Received: 20 March 2024

Accepted: 17 July 2024

First Online: 26 July 2024

Declarations

:

: We confirm that we have read the journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.

: As the study was retrospective in nature, patient consent was institutionally waived.

: Permission to reproduce material from other sources: N/A.

: SW and PM report honoraria from LivaNova, Eisai, UCB, Sunovion, Greenwich Pharmaceuticals, JAZZ, Marinus, Zogenix and participation as an investigator in clinical trials for Zogenix, GW Pharma, NeuroPace, Neurelis, UCB, Eisai. CM reports honoraria from Monteris and LivaNova, and participation as an investigator in a clinical trial for NeuroPace. The remaining co-investigators report no commercial or financial relationships that could be construed as a potential conflict of interest.

Document is current

Any future updates will be listed below